...
机译:Amsterdam Rebus Progressor Cohort:鉴定165个Barrett的监测患者,他们进入早期肿瘤和723名非竞争患者
Acad Med Ctr Dept Gastroenterol &
Hepatol Amsterdam Netherlands;
Acad Med Ctr Dept Gastroenterol &
Hepatol Amsterdam Netherlands;
Acad Med Ctr Dept Gastroenterol &
Hepatol Amsterdam Netherlands;
Acad Med Ctr Dept Gastroenterol &
Hepatol Amsterdam Netherlands;
Acad Med Ctr Dept Pathol Amsterdam Netherlands;
Acad Med Ctr Dept Pathol Amsterdam Netherlands;
Acad Med Ctr Dept Pathol Amsterdam Netherlands;
Acad Med Ctr Dept Pathol Amsterdam Netherlands;
Catharina Hosp Dept Pathol Eindhoven Netherlands;
Acad Med Ctr Dept Gastroenterol &
Hepatol Amsterdam Netherlands;
St Antonius Hosp Dept Gastroenterol Nieuwegein Netherlands;
Catharina Hosp Dept Gastroenterol Eindhoven Netherlands;
Flevoziekenhuis Dept Gastroenterol Almere Netherlands;
Acad Med Ctr Dept Gastroenterol &
Hepatol Amsterdam Netherlands;
Acad Med Ctr Dept Gastroenterol &
Hepatol Amsterdam Netherlands;
biological markers; esophageal cancer; neoplastic progression;
机译:Amsterdam Rebus Progressor Cohort:鉴定165个Barrett的监测患者,他们进入早期肿瘤和723名非竞争患者
机译:对巴雷特肿瘤的内镜粘膜释放解剖:经验十年,进展情况一点。 是ESD最适合复杂的Barrett的肿瘤吗?
机译:无效的监测不能改善患有腺癌的Barrett病患者的生存
机译:区块链和患者信息保护:使用区块链保护符合HIPAA(正在进行的工作)的患者信息
机译:宫颈癌或癌症患者中HPV-16 E7 HLA-DR限制性表位的鉴定和功能分析。
机译:感染者与非感染者HIV-1感染者淋巴组织中IFN-α和TRAIL / DR5的差异表达
机译:感染者与非感染者HIV-1感染者淋巴组织中IFN-α和TRAIL / DR5的差异表达